Ascentage Pharma Group International

Form 4F-120-F

Insider Trading (Form 4)

NASDAQ
AAPG
Ascentage Pharma Group International
Form 4: Ascentage Pharma CMO Equity Grant and Vesting Update
Chief Medical Officer Yifan Zhai reported the acquisition and vesting of restricted stock units and options in Ascentage Pharma Group International.
NASDAQ
AAPG
Ascentage Pharma Group International
Form 4: Ascentage Pharma CEO Dajun Yang Reports Equity Transactions
Ascentage Pharma Group International Chairman and CEO Dajun Yang disclosed the acquisition and vesting of restricted stock units and options in a recent SEC Form 4 filing.
NASDAQ
AAPG
Ascentage Pharma Group International
Form 4: Ascentage Pharma CFO Reports Stock Unit Vesting
Ascentage Pharma Group International's Chief Financial Officer, Veet Misra, reported the vesting of 18,584 restricted stock units on April 20, 2026.